{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:48:06Z","timestamp":1790880486089,"version":"4.1.0"},"publisher-location":"Cham","reference-count":192,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031879180","type":"print"},{"value":"9783031879197","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-3-031-87919-7_12","type":"book-chapter","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T17:52:32Z","timestamp":1749664352000},"page":"317-361","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Oligodendrocyte and Myelin Pathophysiology in Multiple Sclerosis"],"prefix":"10.1007","author":[{"given":"Eneritz","family":"L\u00f3pez-Muguruza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Peir\u00f3-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asier","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Matute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"12_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/WCO.0000000000000818","volume":"33","author":"M Absinta","year":"2020","unstructured":"Absinta, M., Lassmann, H., & Trapp, B. D. (2020). Mechanisms underlying progression in multiple sclerosis. Current Opinion in Neurology, 33, 277\u2013285.","journal-title":"Current Opinion in Neurology"},{"key":"12_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/1352458517740641","volume":"25","author":"MA Agius","year":"2019","unstructured":"Agius, M. A., Klodowska-Duda, G., Maciejowski, M., Potemkowski, A., Li, J., Patra, K., Wesley, J., Madani, S., Barron, G., Katz, E., & Flor, A. (2019). Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomized, placebo-controlled, escalating intravenous and subcutaneous dose study. Multiple Sclerosis, 25, 235\u2013245.","journal-title":"Multiple Sclerosis"},{"key":"12_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1750-3639.2006.00043.x","volume":"17","author":"M Albert","year":"2007","unstructured":"Albert, M., Antel, J., Br\u00fcck, W., & Stadelmann, C. (2007). Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathology, 17, 129\u2013138.","journal-title":"Brain Pathology"},{"key":"12_CR4","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028944","volume":"9","author":"L Alfredsson","year":"2019","unstructured":"Alfredsson, L., & Olsson, T. (2019). Lifestyle and environmental factors in multiple sclerosis. Cold Spring Harbor Perspectives in Medicine, 9, a028944.","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"12_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1586\/14737175.2013.865866","volume":"13","author":"A Ascherio","year":"2013","unstructured":"Ascherio, A. (2013). Environmental factors in multiple sclerosis. Expert Review of Neurotherapeutics, 13, 3\u20139.","journal-title":"Expert Review of Neurotherapeutics"},{"key":"12_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/ana.20016","volume":"55","author":"MH Barnett","year":"2004","unstructured":"Barnett, M. H., & Prineas, J. W. (2004). Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Annals of Neurology, 55, 458\u2013468.","journal-title":"Annals of Neurology"},{"key":"12_CR7","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S1474-4422(21)00063-6","volume":"20","author":"A Bar-Or","year":"2021","unstructured":"Bar-Or, A., & Li, R. (2021). Cellular immunology of relapsing multiple sclerosis: Interactions, checks, and balances. Lancet Neurology, 20, 470\u2013483.","journal-title":"Lancet Neurology"},{"key":"12_CR8","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1177\/1352458517732844","volume":"23","author":"C Barro","year":"2017","unstructured":"Barro, C., Leocani, L., Leppert, D., Comi, G., Kappos, L., & Kuhle, J. (2017). Fluid biomarker and electrophysiological outcome measures for progressive MS trials. Multiple Sclerosis, 23, 1600\u20131613.","journal-title":"Multiple Sclerosis"},{"key":"12_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1017\/S1355617706060723","volume":"12","author":"RHB Benedict","year":"2006","unstructured":"Benedict, R. H. B., Cookfair, D., Gavett, R., Gunther, M., Munschauer, F., Garg, N., & Weinstock-Guttman, B. (2006). Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). Journal of the International Neuropsychological Society, 12, 549\u2013558.","journal-title":"Journal of the International Neuropsychological Society"},{"key":"12_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1076\/clin.16.3.381.13859","volume":"16","author":"RHB Benedict","year":"2002","unstructured":"Benedict, R. H. B., Fischer, J. S., Archibald, C. J., Arnett, P. A., Beatty, W. W., Bobholz, J., Chelune, G. J., Fisk, J. D., Langdon, D. W., Caruso, L., Foley, F., LaRocca, N. G., Vowels, L., Weinstein, A., DeLuca, J., Rao, S. M., & Munschauer, F. (2002). Minimal neuropsychological assessment of MS patients: A consensus approach. The Clinical Neuropsychologist, 16, 381\u2013397.","journal-title":"The Clinical Neuropsychologist"},{"key":"12_CR11","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.devcel.2015.01.016","volume":"32","author":"KK Bercury","year":"2015","unstructured":"Bercury, K. K., & Macklin, W. B. (2015). Dynamics and mechanisms of CNS myelination. Developmental Cell, 32, 447\u2013458.","journal-title":"Developmental Cell"},{"key":"12_CR12","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41573-022-00477-5","volume":"21","author":"L Bierhansl","year":"2022","unstructured":"Bierhansl, L., Hartung, H.-P., Aktas, O., Ruck, T., Roden, M., & Meuth, S. G. (2022). Thinking outside the box: Non-canonical targets in multiple sclerosis. Nature Reviews. Drug Discovery, 21, 578\u2013600.","journal-title":"Nature Reviews. Drug Discovery"},{"key":"12_CR13","first-page":"725","volume":"52","author":"M Bishop","year":"2015","unstructured":"Bishop, M., & Rumrill, P. D. (2015). Multiple sclerosis: Etiology, symptoms, incidence and prevalence, and implications for community living and employment. WORK: A Journal of Prevention, Assessment & Rehabilitation, 52, 725\u2013734.","journal-title":"WORK: A Journal of Prevention, Assessment & Rehabilitation"},{"key":"12_CR14","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/nm.3303","volume":"19","author":"S Bittner","year":"2013","unstructured":"Bittner, S., Ruck, T., Schuhmann, M. K., Herrmann, A. M., Moha ou Maati, H., Bobak, N., G\u00f6bel, K., Langhauser, F., Stegner, D., Ehling, P., Borsotto, M., Pape, H.-C., Nieswandt, B., Kleinschnitz, C., Heurteaux, C., Galla, H.-J., Budde, T., Wiendl, H., & Meuth, S. G. (2013). Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. Nature Medicine, 19, 1161\u20131165.","journal-title":"Nature Medicine"},{"key":"12_CR15","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/jnr.24224","volume":"96","author":"I Bjelobaba","year":"2018","unstructured":"Bjelobaba, I., Begovic-Kupresanin, V., Pekovic, S., & Lavrnja, I. (2018). Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis. Journal of Neuroscience Research, 96, 1021\u20131042.","journal-title":"Journal of Neuroscience Research"},{"key":"12_CR16","first-page":"193","volume-title":"Advances in multiple sclerosis and experimental demyelinating diseases, current topics in microbiology and immunology","author":"WF Blakemore","year":"2008","unstructured":"Blakemore, W. F., & Franklin, R. J. M. (2008). Remyelination in experimental models of toxin-induced demyelination. In M. Rodriguez (Ed.), Advances in multiple sclerosis and experimental demyelinating diseases, current topics in microbiology and immunology (pp. 193\u2013212). Springer."},{"key":"12_CR17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/glia.22443","volume":"61","author":"CF Brosnan","year":"2013","unstructured":"Brosnan, C. F., & Raine, C. S. (2013). The astrocyte in multiple sclerosis revisited. Glia, 61, 453\u2013465.","journal-title":"Glia"},{"key":"12_CR18","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/S0140-6736(16)30959-X","volume":"389","author":"WJ Brownlee","year":"2017","unstructured":"Brownlee, W. J., Hardy, T. A., Fazekas, F., & Miller, D. H. (2017). Diagnosis of multiple sclerosis: Progress and challenges. Lancet Lond, 389, 1336\u20131346.","journal-title":"Lancet Lond"},{"key":"12_CR19","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1001\/jamaneurol.2022.1025","volume":"79","author":"A Cagol","year":"2022","unstructured":"Cagol, A., Schaedelin, S., Barakovic, M., Benkert, P., Todea, R.-A., Rahmanzadeh, R., Galbusera, R., Lu, P.-J., Weigel, M., Melie-Garcia, L., Ruberte, E., Siebenborn, N., Battaglini, M., Radue, E.-W., Yaldizli, \u00d6., Oechtering, J., Sinnecker, T., Lorscheider, J., Fischer-Barnicol, B., M\u00fcller, S., Achtnichts, L., Vehoff, J., Disanto, G., Findling, O., Chan, A., Salmen, A., Pot, C., Bridel, C., Zecca, C., Derfuss, T., Lieb, J. M., Remonda, L., Wagner, F., Vargas, M. I., Du Pasquier, R., Lalive, P. H., Pravat\u00e0, E., Weber, J., Cattin, P. C., Gobbi, C., Leppert, D., Kappos, L., Kuhle, J., & Granziera, C. (2022). Association of brain atrophy with disease progression independent of relapse activity in patients with relapsing multiple sclerosis. JAMA Neurology, 79, 682\u2013692.","journal-title":"JAMA Neurology"},{"key":"12_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1089\/dna.2018.4496","volume":"38","author":"AV Caprariello","year":"2019","unstructured":"Caprariello, A. V., & Stys, P. K. (2019). Turned inside out: Will myelin-protective therapies become the next-generation anti-inflammatories? DNA and Cell Biology, 38, 219\u2013222.","journal-title":"DNA and Cell Biology"},{"key":"12_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/ni1551","volume":"9","author":"R Cayrol","year":"2008","unstructured":"Cayrol, R., Wosik, K., Berard, J. L., Dodelet-Devillers, A., Ifergan, I., Kebir, H., Haqqani, A. S., Kreymborg, K., Krug, S., Moumdjian, R., Bouthillier, A., Becher, B., Arbour, N., David, S., Stanimirovic, D., & Prat, A. (2008). Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nature Immunology, 9, 137\u2013145.","journal-title":"Nature Immunology"},{"key":"12_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10571-014-0092-3","volume":"35","author":"A Cisneros-Mejorado","year":"2015","unstructured":"Cisneros-Mejorado, A., P\u00e9rez-Samart\u00edn, A., Gottlieb, M., & Matute, C. (2015). ATP signaling in brain: Release, excitotoxicity and potential therapeutic targets. Cellular and Molecular Neurobiology, 35, 1\u20136.","journal-title":"Cellular and Molecular Neurobiology"},{"key":"12_CR23","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.4049\/jimmunol.0803418","volume":"182","author":"C Coisne","year":"2009","unstructured":"Coisne, C., Mao, W., & Engelhardt, B. (2009). Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis. Journal of Immunology, 182, 5909\u20135913.","journal-title":"Journal of Immunology"},{"key":"12_CR24","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000117","volume":"2","author":"CS Constantinescu","year":"2015","unstructured":"Constantinescu, C. S., Asher, A., Fryze, W., Kozubski, W., Wagner, F., Aram, J., Tanasescu, R., Korolkiewicz, R. P., Dirnberger-Hertweck, M., Steidl, S., Libretto, S. E., Sprenger, T., & Radue, E. W. (2015). Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis. Neurology Neuroimmunology & Neuroinflammation, 2, e117.","journal-title":"Neurology Neuroimmunology & Neuroinflammation"},{"key":"12_CR25","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"CS Constantinescu","year":"2011","unstructured":"Constantinescu, C. S., Farooqi, N., O\u2019Brien, K., & Gran, B. (2011). Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). British Journal of Pharmacology, 164, 1079\u20131106.","journal-title":"British Journal of Pharmacology"},{"key":"12_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.expneurol.2014.04.027","volume":"260","author":"AH Crawford","year":"2014","unstructured":"Crawford, A. H., Stockley, J. H., Tripathi, R. B., Richardson, W. D., & Franklin, R. J. M. (2014). Oligodendrocyte progenitors: Adult stem cells of the central nervous system? Experimental Neurology, 260, 50\u201355.","journal-title":"Experimental Neurology"},{"key":"12_CR27","unstructured":"Cunniffe, N. (2023). CCMR two: A phase IIa, randomised, double-blind, placebo-controlled trial of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy http:\/\/clinicaltrials.gov"},{"key":"12_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106230","volume":"184","author":"S Dedoni","year":"2023","unstructured":"Dedoni, S., Scherma, M., Camoglio, C., Siddi, C., Dazzi, L., Puliga, R., Frau, J., Cocco, E., & Fadda, P. (2023). An overall view of the most common experimental models for multiple sclerosis. Neurobiology of Disease, 184, 106230.","journal-title":"Neurobiology of Disease"},{"key":"12_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2021.109088","volume":"352","author":"S Dehghan","year":"2021","unstructured":"Dehghan, S., Aref, E., Raoufy, M. R., & Javan, M. (2021). An optimized animal model of lysolecithin induced demyelination in optic nerve; more feasible, more reproducible, promising for studying the progressive forms of multiple sclerosis. Journal of Neuroscience Methods, 352, 109088.","journal-title":"Journal of Neuroscience Methods"},{"key":"12_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou, C. A., Fugger, L., & Friese, M. A. (2015). Immunopathology of multiple sclerosis. Nature Reviews. Immunology, 15, 545\u2013558.","journal-title":"Nature Reviews. Immunology"},{"key":"12_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pathophys.2010.04.004","volume":"18","author":"A Denic","year":"2011","unstructured":"Denic, A., Johnson, A. J., Bieber, A. J., Warrington, A. E., Rodriguez, M., & Pirko, I. (2011). The relevance of animal models in multiple sclerosis research. Pathophysiology, 18, 21\u201329.","journal-title":"Pathophysiology"},{"key":"12_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40263-022-00977-3","volume":"37","author":"NG Dimitriou","year":"2023","unstructured":"Dimitriou, N. G., Meuth, S. G., Martinez-Lapiscina, E. H., Albrecht, P., & Menge, T. (2023). Treatment of patients with multiple sclerosis transitioning between relapsing and progressive disease. CNS Drugs, 37, 69\u201392.","journal-title":"CNS Drugs"},{"key":"12_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson, R., & Giovannoni, G. (2019). Multiple sclerosis\u2014A review. European Journal of Neurology, 26, 27\u201340.","journal-title":"European Journal of Neurology"},{"key":"12_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.coph.2019.03.010","volume":"47","author":"M Domercq","year":"2019","unstructured":"Domercq, M., & Matute, C. (2019). Targeting P2X4 and P2X7 receptors in multiple sclerosis. Current Opinion in Pharmacology Cancer Immunomodulation, 47, 119\u2013125.","journal-title":"Current Opinion in Pharmacology Cancer Immunomodulation"},{"key":"12_CR35","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.3390\/ijms21175957","volume":"21","author":"A Dziedzic","year":"2020","unstructured":"Dziedzic, A., Saluk-Bijak, J., Miller, E., & Bijak, M. (2020). Metformin as a potential agent in the treatment of multiple sclerosis. International Journal of Molecular Sciences, 21, 5957.","journal-title":"International Journal of Molecular Sciences"},{"key":"12_CR36","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/j.1750-3639.2010.00401.x","volume":"20","author":"T Dziedzic","year":"2010","unstructured":"Dziedzic, T., Metz, I., Dallenga, T., K\u00f6nig, F. B., M\u00fcller, S., Stadelmann, C., & Br\u00fcck, W. (2010). Wallerian degeneration: A major component of early axonal pathology in multiple sclerosis. Brain Pathology Zurich, 20, 976\u2013985.","journal-title":"Brain Pathology Zurich"},{"key":"12_CR37","doi-asserted-by":"publisher","first-page":"11112","DOI":"10.3390\/ijms241311112","volume":"24","author":"O Ellen","year":"2023","unstructured":"Ellen, O., Ye, S., Nheu, D., Dass, M., Pagnin, M., Ozturk, E., Theotokis, P., Grigoriadis, N., & Petratos, S. (2023). The heterogeneous multiple sclerosis lesion: How can we assess and modify a degenerating lesion? International Journal of Molecular Sciences, 24, 11112.","journal-title":"International Journal of Molecular Sciences"},{"key":"12_CR38","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.it.2012.07.004","volume":"33","author":"B Engelhardt","year":"2012","unstructured":"Engelhardt, B., & Ransohoff, R. M. (2012). Capture, crawl, cross: The T cell code to breach the blood-brain barriers. Trends in Immunology, 33, 579\u2013589.","journal-title":"Trends in Immunology"},{"key":"12_CR39","first-page":"4610","volume":"11","author":"O Fern\u00e1ndez","year":"2015","unstructured":"Fern\u00e1ndez, O., Fern\u00e1ndez, V. E., & Guerrero, M. (2015). Esclerosis m\u00faltiple. Med.\u2014Programa form. M\u00e9dica Contin. Acreditado, 11, 4610\u20134621.","journal-title":"M\u00e9dica Contin. Acreditado"},{"key":"12_CR40","first-page":"1","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018). Multiple sclerosis. Nature Reviews Disease Primers, 4, 1\u201327.","journal-title":"Nature Reviews Disease Primers"},{"key":"12_CR41","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S1474-4422(18)30451-4","volume":"18","author":"M Filippi","year":"2019","unstructured":"Filippi, M., Br\u00fcck, W., Chard, D., Fazekas, F., Geurts, J. J. G., Enzinger, C., Hametner, S., Kuhlmann, T., Preziosa, P., Rovira, \u00c0., Schmierer, K., Stadelmann, C., & Rocca, M. A. (2019). Association between pathological and MRI findings in multiple sclerosis. Lancet Neurology, 18, 198\u2013210.","journal-title":"Lancet Neurology"},{"key":"12_CR42","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nrn.2017.136","volume":"18","author":"RJM Franklin","year":"2017","unstructured":"Franklin, R. J. M., & Ffrench-Constant, C. (2017). Regenerating CNS myelin\u2014From mechanisms to experimental medicines. Nature Reviews. Neuroscience, 18, 753\u2013769.","journal-title":"Nature Reviews. Neuroscience"},{"key":"12_CR43","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nrneurol.2012.200","volume":"8","author":"RJM Franklin","year":"2012","unstructured":"Franklin, R. J. M., Ffrench-Constant, C., Edgar, J. M., & Smith, K. J. (2012). Neuroprotection and repair in multiple sclerosis. Nature Reviews. Neurology, 8, 624\u2013634.","journal-title":"Nature Reviews. Neurology"},{"key":"12_CR44","doi-asserted-by":"publisher","first-page":"e762","DOI":"10.1212\/WNL.0000000000200606","volume":"99","author":"MS Freedman","year":"2022","unstructured":"Freedman, M. S., Pozzilli, C., Havrdova, E. K., Lemle, A., Burcklen, M., Larbalestier, A., Hennessy, B., Sidorenko, T., Vaclavkova, A., Olsson, T., & on behalf of the Ponesimod Phase II Study Group. (2022). Long-term treatment with Ponesimod in relapsing-remitting multiple sclerosis. Neurology, 99, e762\u2013e774.","journal-title":"Neurology"},{"key":"12_CR45","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nature11007","volume":"485","author":"U Funfschilling","year":"2012","unstructured":"Funfschilling, U., Supplie, L. M., Mahad, D., Boretius, S., Saab, A. S., Edgar, J., Brinkmann, B. G., Kassmann, C. M., Tzvetanova, I. D., Mobius, W., Diaz, F., Meijer, D., Suter, U., Hamprecht, B., Sereda, M. W., Moraes, C. T., Frahm, J., Goebbels, S., & Nave, K.-A. (2012). Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature, 485, 517\u2013521.","journal-title":"Nature"},{"key":"12_CR46","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000135","volume":"2","author":"SL Galetta","year":"2015","unstructured":"Galetta, S. L., Villoslada, P., Levin, N., Shindler, K., Ishikawa, H., Parr, E., Cadavid, D., & Balcer, L. J. (2015). Acute optic neuritis: Unmet clinical needs and model for new therapies. Neurology Neuroimmunology & Neuroinflammation, 2, e135.","journal-title":"Neurology Neuroimmunology & Neuroinflammation"},{"key":"12_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.362","volume":"5","author":"N Garg","year":"2015","unstructured":"Garg, N., & Smith, T. W. (2015). An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis. Brain and Behavior: A Cognitive Neuroscience Perspective, 5, e00362.","journal-title":"Brain and Behavior: A Cognitive Neuroscience Perspective"},{"key":"12_CR48","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s40263-022-00951-z","volume":"36","author":"A Geladaris","year":"2022","unstructured":"Geladaris, A., Torke, S., & Weber, M. S. (2022). Bruton\u2019s tyrosine kinase inhibitors in multiple sclerosis: Pioneering the path towards treatment of progression? CNS Drugs, 36, 1019\u20131030.","journal-title":"CNS Drugs"},{"key":"12_CR49","unstructured":"Genentech: Statements | Fenebrutinib Multiple Sclerosis Clinical Trial Program Update [WWW Document], n.d.. https:\/\/www.gene.com\/media\/statements\/ps_113023. Accessed 18 Jan 2024"},{"key":"12_CR50","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028977","volume":"8","author":"S Glatigny","year":"2018","unstructured":"Glatigny, S., & Bettelli, E. (2018). Experimental autoimmune encephalomyelitis (EAE) as animal models of multiple sclerosis (MS). Cold Spring Harbor Perspectives in Medicine, 8, a028977.","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"12_CR51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1073\/pnas.1810020116","volume":"116","author":"K G\u00f6bel","year":"2019","unstructured":"G\u00f6bel, K., Asaridou, C.-M., Merker, M., Eichler, S., Herrmann, A. M., Geu\u00df, E., Ruck, T., Sch\u00fcngel, L., Groeneweg, L., Narayanan, V., Schneider-Hohendorf, T., Gross, C. C., Wiendl, H., Kehrel, B. E., Kleinschnitz, C., & Meuth, S. G. (2019). Plasma kallikrein modulates immune cell trafficking during neuroinflammation via PAR2 and bradykinin release. Proceedings of the National Academy of Sciences of the United States of America, 116, 271\u2013276.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"12_CR52","doi-asserted-by":"publisher","first-page":"10738","DOI":"10.3390\/ijms221910738","volume":"22","author":"U G\u00f3mez-Pinedo","year":"2021","unstructured":"G\u00f3mez-Pinedo, U., Mat\u00edas-Guiu, J. A., Benito-Mart\u00edn, M. S., Moreno-Jim\u00e9nez, L., Sanclemente-Alam\u00e1n, I., Selma-Calvo, B., P\u00e9rez-Suarez, S., Sancho-Bielsa, F., Canales-Aguirre, A., Mateos-D\u00edaz, J. C., Hern\u00e1ndez-Sapi\u00e9ns, M. A., Reza-Zald\u00edvar, E. E., Ojeda-Hern\u00e1ndez, D. D., Vidorreta-Ballesteros, L., Montero-Escribano, P., & Mat\u00edas-Guiu, J. (2021). Intranasal administration of undifferentiated oligodendrocyte lineage cells as a potential approach to deliver oligodendrocyte precursor cells into brain. International Journal of Molecular Sciences, 22, 10738.","journal-title":"International Journal of Molecular Sciences"},{"key":"12_CR53","first-page":"173","volume-title":"Handbook of clinical neurology","author":"DS Goodin","year":"2016","unstructured":"Goodin, D. S. (2016). The epidemiology of multiple sclerosis. In Handbook of clinical neurology (pp. 173\u2013206). Elsevier."},{"key":"12_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246157","volume":"16","author":"DS Goodin","year":"2021","unstructured":"Goodin, D. S., Khankhanian, P., Gourraud, P.-A., & Vince, N. (2021). The nature of genetic and environmental susceptibility to multiple sclerosis. PLoS One, 16, e0246157.","journal-title":"PLoS One"},{"key":"12_CR55","doi-asserted-by":"publisher","first-page":"8662","DOI":"10.3390\/ijms21228662","volume":"21","author":"A Gugliandolo","year":"2020","unstructured":"Gugliandolo, A., Bramanti, P., & Mazzon, E. (2020). Mesenchymal stem cells in multiple sclerosis: Recent evidence from pre-clinical to clinical studies. International Journal of Molecular Sciences, 21, 8662.","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"12_CR56","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1242\/jcs.10.2.535","volume":"10","author":"SM Hall","year":"1972","unstructured":"Hall, S. M. (1972). The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. Journal of Cell Science, 10(2), 535\u2013546.","journal-title":"Journal of Cell Science"},{"key":"12_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.711362","volume":"12","author":"J He","year":"2021","unstructured":"He, J., Huang, Y., Liu, J., Lan, Z., Tang, X., & Hu, Z. (2021). The efficacy of mesenchymal stem cell therapies in rodent models of multiple sclerosis: An updated systematic review and meta-analysis. Frontiers in Immunology, 12, 711362.","journal-title":"Frontiers in Immunology"},{"key":"12_CR58","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00401-020-02189-9","volume":"140","author":"K He\u00df","year":"2020","unstructured":"He\u00df, K., Starost, L., Kieran, N. W., Thomas, C., Vincenten, M. C. J., Antel, J., Martino, G., Huitinga, I., Healy, L., & Kuhlmann, T. (2020). Lesion stage-dependent causes for impaired remyelination in MS. Acta neuropathologica (Berl.), 140, 359\u2013375.","journal-title":"Acta neuropathologica (Berl.)"},{"key":"12_CR59","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/B978-0-12-802395-2.00019-5","volume":"145","author":"R H\u00f6ftberger","year":"2017","unstructured":"H\u00f6ftberger, R., & Lassmann, H. (2017). Inflammatory demyelinating diseases of the central nervous system. Handbook of Clinical Neurology, 145, 263\u2013283.","journal-title":"Handbook of Clinical Neurology"},{"key":"12_CR60","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S1474-4422(15)00334-8","volume":"15","author":"R Hohlfeld","year":"2016","unstructured":"Hohlfeld, R., Dornmair, K., Meinl, E., & Wekerle, H. (2016). The search for the target antigens of multiple sclerosis, part 1: Autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets. Lancet Neurology, 15, 198\u2013209.","journal-title":"Lancet Neurology"},{"key":"12_CR61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jaut.2015.06.010","volume":"64","author":"JA Hollenbach","year":"2015","unstructured":"Hollenbach, J. A., & Oksenberg, J. R. (2015). The immunogenetics of multiple sclerosis: A comprehensive review. Journal of Autoimmunity, 64, 13\u201325.","journal-title":"Journal of Autoimmunity"},{"key":"12_CR62","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41598-018-35734-4","volume":"9","author":"CR Hooijmans","year":"2019","unstructured":"Hooijmans, C. R., Hlavica, M., Schuler, F. A. F., Good, N., Good, A., Baumgartner, L., Galeno, G., Schneider, M. P., Jung, T., de Vries, R., & Ineichen, B. V. (2019). Remyelination promoting therapies in multiple sclerosis animal models: A systematic review and meta-analysis. Scientific Reports, 9, 822.","journal-title":"Scientific Reports"},{"key":"12_CR63","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2463\/mrms.rev.2021-0091","volume":"21","author":"M Hori","year":"2022","unstructured":"Hori, M., Maekawa, T., Kamiya, K., Hagiwara, A., Goto, M., Takemura, M. Y., Fujita, S., Andica, C., Kamagata, K., Cohen-Adad, J., & Aoki, S. (2022). Advanced diffusion MR imaging for multiple sclerosis in the brain and spinal cord. Magnetic Resonance in Medical Sciences, 21, 58\u201370.","journal-title":"Magnetic Resonance in Medical Sciences"},{"key":"12_CR64","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.3892\/etm.2017.4410","volume":"13","author":"W-J Huang","year":"2017","unstructured":"Huang, W.-J., Chen, W.-W., & Zhang, X. (2017). Multiple sclerosis: Pathology, diagnosis and treatments. Experimental and Therapeutic Medicine, 13, 3163\u20133166.","journal-title":"Experimental and Therapeutic Medicine"},{"key":"12_CR65","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.tins.2023.11.005","volume":"47","author":"L Husseini","year":"2024","unstructured":"Husseini, L., Geladaris, A., & Weber, M. S. (2024). Toward identifying key mechanisms of progression in multiple sclerosis. Trends in Neurosciences, 47, 58\u201370.","journal-title":"Trends in Neurosciences"},{"key":"12_CR66","doi-asserted-by":"publisher","first-page":"570","DOI":"10.2174\/187152712801661284","volume":"11","author":"J Van Der Star","year":"2012","unstructured":"Van Der Star, J., B., Y.S, Vogel, D., Kipp, M., Puentes, F., Baker, D., & Amor, S. (2012). In vitro and in vivo models of multiple sclerosis. CNS & Neurological Disorders\u2014Drug Targets, 11, 570\u2013588.","journal-title":"CNS & Neurological Disorders\u2014Drug Targets"},{"key":"12_CR67","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41577-021-00652-6","volume":"22","author":"RW Jain","year":"2022","unstructured":"Jain, R. W., & Yong, V. W. (2022). B cells in central nervous system disease: Diversity, locations and pathophysiology. Nature Reviews. Immunology, 22, 513\u2013524.","journal-title":"Nature Reviews. Immunology"},{"key":"12_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.850616","volume":"13","author":"H Jamann","year":"2022","unstructured":"Jamann, H., Cui, Q.-L., Desu, H. L., Pernin, F., Tastet, O., Halaweh, A., Farzam-Kia, N., Mamane, V. H., Ou\u00e9draogo, O., Cleret-Buhot, A., Daigneault, A., Balthazard, R., Klement, W., Lema\u00eetre, F., Arbour, N., Antel, J., Stratton, J. A., & Larochelle, C. (2022). Contact-dependent Granzyme B-mediated cytotoxicity of Th17-polarized cells toward human oligodendrocytes. Frontiers in Immunology, 13, 850616.","journal-title":"Frontiers in Immunology"},{"key":"12_CR69","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1517\/17425247.2011.566267","volume":"8","author":"Y Jiang","year":"2011","unstructured":"Jiang, Y., Zhu, J., Xu, G., & Liu, X. (2011). Intranasal delivery of stem cells to the brain. Expert Opinion on Drug Delivery, 8, 623\u2013632.","journal-title":"Expert Opinion on Drug Delivery"},{"key":"12_CR70","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s40265-013-0146-8","volume":"73","author":"E Jolanda M\u00fcnzel","year":"2013","unstructured":"Jolanda M\u00fcnzel, E., & Williams, A. (2013). Promoting remyelination in multiple sclerosis\u2014recent advances. Drugs, 73, 2017\u20132029.","journal-title":"Drugs"},{"key":"12_CR71","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/brain\/awv353","volume":"139","author":"T J\u00fcrgens","year":"2016","unstructured":"J\u00fcrgens, T., Jafari, M., Kreutzfeldt, M., Bahn, E., Br\u00fcck, W., Kerschensteiner, M., & Merkler, D. (2016). Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis. Brain: A Journal of Neurology, 139, 39\u201346.","journal-title":"Brain: A Journal of Neurology"},{"key":"12_CR72","first-page":"636","volume":"25","author":"OH Kantarci","year":"2019","unstructured":"Kantarci, O. H. (2019). Phases and phenotypes of multiple sclerosis. Continuum: Lifelong Learning in Neurology, 25, 636.","journal-title":"Continuum: Lifelong Learning in Neurology"},{"key":"12_CR73","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1177\/1352458517728343","volume":"24","author":"L Kappos","year":"2018","unstructured":"Kappos, L., Arnold, D. L., Bar-Or, A., Camm, A. J., Derfuss, T., Sprenger, T., Davies, M., Piotrowska, A., Ni, P., & Harada, T. (2018). Two-year results from a phase 2 extension study of oral amiselimod in relapsing multiple sclerosis. Multiple Sclerosis Journal, 24, 1605\u20131616.","journal-title":"Multiple Sclerosis Journal"},{"key":"12_CR74","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1212\/WNL.0b013e3181c97c8f","volume":"74","author":"LH Kasper","year":"2010","unstructured":"Kasper, L. H., & Shoemaker, J. (2010). Multiple sclerosis immunology: The healthy immune system vs the MS immune system. Neurology, 74, S2\u2013S8.","journal-title":"Neurology"},{"key":"12_CR75","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.stemcr.2017.01.007","volume":"8","author":"I Kazanis","year":"2017","unstructured":"Kazanis, I., Evans, K. A., Andreopoulou, E., Dimitriou, C., Koutsakis, C., Karadottir, R. T., & Franklin, R. J. M. (2017). Subependymal zone-derived oligodendroblasts respond to focal demyelination but fail to generate myelin in young and aged mice. Stem Cell Reports, 8, 685\u2013700.","journal-title":"Stem Cell Reports"},{"key":"12_CR76","first-page":"52679","volume-title":"Experimental demyelination and Remyelination of murine spinal cord by focal injection of Lysolecithin","author":"MB Keough","year":"2015","unstructured":"Keough, M. B., Jensen, S. K., & Yong, V. W. (2015). Experimental demyelination and Remyelination of murine spinal cord by focal injection of Lysolecithin (p. 52679). JoVE."},{"key":"12_CR77","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/bpa.12454","volume":"27","author":"M Kipp","year":"2017","unstructured":"Kipp, M., Nyamoya, S., Hochstrasser, T., & Amor, S. (2017). Multiple sclerosis animal models: A clinical and histopathological perspective. Brain Pathology, 27, 123\u2013137.","journal-title":"Brain Pathology"},{"key":"12_CR78","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1038\/s41467-019-11638-3","volume":"10","author":"L Kirby","year":"2019","unstructured":"Kirby, L., Jin, J., Cardona, J. G., Smith, M. D., Martin, K. A., Wang, J., Strasburger, H., Herbst, L., Alexis, M., Karnell, J., Davidson, T., Dutta, R., Goverman, J., Bergles, D., & Calabresi, P. A. (2019). Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination. Nature Communications, 10, 3887.","journal-title":"Nature Communications"},{"key":"12_CR79","doi-asserted-by":"publisher","first-page":"146","DOI":"10.7224\/1537-2073.2012-053","volume":"15","author":"I Kister","year":"2013","unstructured":"Kister, I., Bacon, T. E., Chamot, E., Salter, A. R., Cutter, G. R., Kalina, J. T., & Herbert, J. (2013). Natural history of multiple sclerosis symptoms. International Journal of MS Care, 15, 146\u2013156.","journal-title":"International Journal of MS Care"},{"key":"12_CR80","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0002-9440(10)64537-3","volume":"157","author":"B Kornek","year":"2000","unstructured":"Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T., Linington, C., Schmidbauer, M., & Lassmann, H. (2000). Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. The American Journal of Pathology, 157, 267\u2013276.","journal-title":"The American Journal of Pathology"},{"key":"12_CR81","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1523\/JNEUROSCI.2615-05.2006","volume":"26","author":"MR Kotter","year":"2006","unstructured":"Kotter, M. R., Li, W.-W., Zhao, C., & Franklin, R. J. M. (2006). Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 26, 328\u2013332.","journal-title":"Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"key":"12_CR82","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/1352458518800827","volume":"25","author":"D Kremer","year":"2019","unstructured":"Kremer, D., Akkermann, R., K\u00fcry, P., & Dutta, R. (2019). Current advancements in promoting remyelination in multiple sclerosis. Multiple Sclerosis Journal, 25, 7\u201314.","journal-title":"Multiple Sclerosis Journal"},{"key":"12_CR83","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1093\/brain\/awf235","volume":"125","author":"T Kuhlmann","year":"2002","unstructured":"Kuhlmann, T., Lingfeld, G., Bitsch, A., Schuchardt, J., & Br\u00fcck, W. (2002). Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain: A Journal of Neurology, 125, 2202\u20132212.","journal-title":"Brain: A Journal of Neurology"},{"key":"12_CR84","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1093\/brain\/awh641","volume":"128","author":"A Kutzelnigg","year":"2005","unstructured":"Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Br\u00fcck, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005). Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain: A Journal of Neurology, 128, 2705\u20132712.","journal-title":"Brain: A Journal of Neurology"},{"key":"12_CR85","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.expneurol.2013.02.014","volume":"247","author":"NJ Kuypers","year":"2013","unstructured":"Kuypers, N. J., James, K. T., Enzmann, G. U., Magnuson, D. S. K., & Whittemore, S. R. (2013). Functional consequences of ethidium bromide demyelination of the mouse ventral spinal cord. Experimental Neurology, 247, 615\u2013622.","journal-title":"Experimental Neurology"},{"key":"12_CR86","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2025813118","volume":"118","author":"C Larochelle","year":"2021","unstructured":"Larochelle, C., Wasser, B., Jamann, H., L\u00f6ffel, J. T., Cui, Q.-L., Tastet, O., Schillner, M., Luchtman, D., Birkenstock, J., Stroh, A., Antel, J., Bittner, S., & Zipp, F. (2021). Pro-inflammatory T helper 17 directly harms oligodendrocytes in neuroinflammation. Proceedings of the National Academy of Sciences of the United States of America, 118, e2025813118.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"12_CR87","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1111\/ene.15360","volume":"29","author":"H Lassmann","year":"2022","unstructured":"Lassmann, H. (2022). The contribution of neuropathology to multiple sclerosis research. European Journal of Neurology, 29, 2869\u20132877.","journal-title":"European Journal of Neurology"},{"key":"12_CR88","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028936","volume":"8","author":"H Lassmann","year":"2018","unstructured":"Lassmann, H. (2018). Multiple sclerosis pathology. Cold Spring Harbor Perspectives in Medicine, 8, a028936.","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"12_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2013.05.010","volume":"333","author":"H Lassmann","year":"2013","unstructured":"Lassmann, H. (2013). Pathology and disease mechanisms in different stages of multiple sclerosis. Journal of the Neurological Sciences, 333, 1\u20134.","journal-title":"Journal of the Neurological Sciences"},{"key":"12_CR90","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","volume":"133","author":"H Lassmann","year":"2017","unstructured":"Lassmann, H., & Bradl, M. (2017). Multiple sclerosis: Experimental models and reality. Acta Neuropathologica (Berl.), 133, 223\u2013244.","journal-title":"Acta Neuropathologica (Berl.)"},{"key":"12_CR91","first-page":"E524","volume":"114","author":"M-A L\u00e9cuyer","year":"2017","unstructured":"L\u00e9cuyer, M.-A., Saint-Laurent, O., Bourbonni\u00e8re, L., Larouche, S., Larochelle, C., Michel, L., Charabati, M., Abadier, M., Zandee, S., Haghayegh Jahromi, N., Gowing, E., Pittet, C., Lyck, R., Engelhardt, B., & Prat, A. (2017). Dual role of ALCAM in neuroinflammation and blood-brain barrier homeostasis. Proceedings of the National Academy of Sciences of the United States of America, 114, E524\u2013E533.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"12_CR92","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature11314","volume":"487","author":"Y Lee","year":"2012","unstructured":"Lee, Y., Morrison, B. M., Li, Y., Lengacher, S., Farah, M. H., Hoffman, P. N., Liu, Y., Tsingalia, A., Jin, L., Zhang, P.-W., Pellerin, L., Magistretti, P. J., & Rothstein, J. D. (2012). Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature, 487, 443\u2013448.","journal-title":"Nature"},{"key":"12_CR93","doi-asserted-by":"publisher","first-page":"16093","DOI":"10.3390\/ijms232416093","volume":"23","author":"H Leo","year":"2022","unstructured":"Leo, H., & Kipp, M. (2022). Remyelination in multiple sclerosis: Findings in the Cuprizone model. International Journal of Molecular Sciences, 23, 16093.","journal-title":"International Journal of Molecular Sciences"},{"key":"12_CR94","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.stem.2023.11.001","volume":"30","author":"MA Leone","year":"2023","unstructured":"Leone, M. A., Gelati, M., Profico, D. C., Gobbi, C., Pravat\u00e0, E., Copetti, M., Conti, C., Abate, L., Amoruso, L., Apollo, F., Balzano, R. F., Bicchi, I., Carella, M., Ciampini, A., Colosimo, C., Crociani, P., D\u2019Aloisio, G., Di Viesti, P., Ferrari, D., Fogli, D., Fontana, A., Frondizi, D., Grespi, V., Kuhle, J., Laborante, A., Lombardi, I., Muzi, G., Paci, F., Placentino, G., Popolizio, T., Ricciolini, C., Sabatini, S., Silveri, G., Spera, C., Stephenson, D., Stipa, G., Tinella, E., Zarrelli, M., Zecca, C., Ventura, Y., D\u2019Alessandro, A., Peruzzotti-Jametti, L., Pluchino, S., & Vescovi, A. L. (2023). Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis. Cell Stem Cell, 30, 1597\u20131609.e8.","journal-title":"Cell Stem Cell"},{"key":"12_CR95","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11908-017-0562-0","volume":"19","author":"SN Levin","year":"2017","unstructured":"Levin, S. N., & Kaplan, T. B. (2017). Infectious complications of novel multiple sclerosis therapies. Current Infectious Disease Reports, 19, 7.","journal-title":"Current Infectious Disease Reports"},{"key":"12_CR96","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00705-021-04968-5","volume":"166","author":"JE Libbey","year":"2021","unstructured":"Libbey, J. E., & Fujinami, R. S. (2021). Viral mouse models used to study multiple sclerosis: Past and present. Archives of Virology, 166, 1015\u20131033.","journal-title":"Archives of Virology"},{"key":"12_CR97","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243014","volume":"16","author":"G Liu","year":"2021","unstructured":"Liu, G., Wu, Y., Kong, F., Ma, S., Fu, L., & Geng, J. (2021). BMSCs differentiated into neurons, astrocytes and oligodendrocytes alleviated the inflammation and demyelination of EAE mice models. PLoS One, 16, e0243014.","journal-title":"PLoS One"},{"key":"12_CR98","doi-asserted-by":"publisher","first-page":"12912","DOI":"10.3390\/ijms241612912","volume":"24","author":"E L\u00f3pez-Muguruza","year":"2023","unstructured":"L\u00f3pez-Muguruza, E., & Matute, C. (2023). Alterations of oligodendrocyte and myelin energy metabolism in multiple sclerosis. International Journal of Molecular Sciences, 24, 12912.","journal-title":"International Journal of Molecular Sciences"},{"key":"12_CR99","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3390\/life12040474","volume":"12","author":"E L\u00f3pez-Muguruza","year":"2022","unstructured":"L\u00f3pez-Muguruza, E., Villar-G\u00f3mez, N., Matias-Guiu, J. A., Selma-Calvo, B., Moreno-Jim\u00e9nez, L., Sancho-Bielsa, F., Lopez-Carbonero, J., Benito-Mart\u00edn, M. S., Garc\u00eda-Flores, S., Bonel-Garc\u00eda, N., Kamal, O. M.-F., Ojeda-Hern\u00e1ndez, D., Mat\u00edas-Guiu, J., & G\u00f3mez-Pinedo, U. (2022). The integration of cell therapy and biomaterials as treatment strategies for Remyelination. Life, 12, 474.","journal-title":"Life"},{"key":"12_CR100","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/978-2-88966-693-5","volume-title":"Editorial: \u201cInside-out\u201d vs \u201coutside-in\u201d paradigms in multiple sclerosis","author":"A Luchicchi","year":"2021","unstructured":"Luchicchi, A., Preziosa, P., & t Hart, B. (2021). Editorial: \u201cInside-out\u201d vs \u201coutside-in\u201d paradigms in multiple sclerosis (p. 15). Etiopathogenesis Frontiers in Cellular Neuroscience."},{"key":"12_CR101","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1126\/science.aaf6463","volume":"352","author":"S Marques","year":"2016","unstructured":"Marques, S., Zeisel, A., Codeluppi, S., van Bruggen, D., Mendanha Falc\u00e3o, A., Xiao, L., Li, H., H\u00e4ring, M., Hochgerner, H., Romanov, R. A., Gyllborg, D., Mu\u00f1oz-Manchado, A. B., La Manno, G., L\u00f6nnerberg, P., Floriddia, E. M., Rezayee, F., Ernfors, P., Arenas, E., Hjerling-Leffler, J., Harkany, T., Richardson, W. D., Linnarsson, S., & Castelo-Branco, G. (2016). Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system. Science, 352, 1326\u20131329.","journal-title":"Science"},{"key":"12_CR102","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/glia.23980","volume":"69","author":"DE Marzan","year":"2021","unstructured":"Marzan, D. E., Br\u00fcgger-Verdon, V., West, B. L., Liddelow, S., Samanta, J., & Salzer, J. L. (2021). Activated microglia drive demyelination via CSF1R signaling. Glia, 69, 1583\u20131604.","journal-title":"Glia"},{"key":"12_CR103","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1469-7580.2010.01339.x","volume":"219","author":"C Matute","year":"2011","unstructured":"Matute, C. (2011). Glutamate and ATP signalling in white matter pathology. Journal of Anatomy, 219, 53\u201364.","journal-title":"Journal of Anatomy"},{"key":"12_CR104","volume-title":"Multiple sclerosis: A reappraisal","author":"D McAlpine","year":"1972","unstructured":"McAlpine, D., Lumsden, C. E., & Acheson, D. (1972). Multiple sclerosis: A reappraisal. Churchill Livingstone."},{"key":"12_CR105","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H. P., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., Sandberg-Wollheim, M., Sibley, W., Thompson, A., van den Noort, S., Weinshenker, B. Y., & Wolinsky, J. S. (2001). Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Annals of Neurology, 50, 121\u2013127.","journal-title":"Annals of Neurology"},{"key":"12_CR106","doi-asserted-by":"publisher","first-page":"ENEURO.0203-18.","DOI":"10.1523\/ENEURO.0203-18.2018","volume":"5","author":"S McDougall","year":"2018","unstructured":"McDougall, S., Vargas Riad, W., Silva-Gotay, A., Tavares, E. R., Harpalani, D., Li, G.-L., & Richardson, H. N. (2018). Myelination of axons corresponds with faster transmission speed in the prefrontal cortex of developing male rats. eNeuro, 5, ENEURO.0203-18.2018.","journal-title":"eNeuro"},{"key":"12_CR107","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/978-1-4939-9072-6_21","volume-title":"Oligodendrocytes: Methods and protocols, methods in molecular biology","author":"CE McMurran","year":"2019","unstructured":"McMurran, C. E., Zhao, C., & Franklin, R. J. M. (2019). Toxin-based models to investigate demyelination and remyelination. In D. A. Lyons & L. Kegel (Eds.), Oligodendrocytes: Methods and protocols, methods in molecular biology (pp. 377\u2013396). Springer."},{"key":"12_CR108","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrn.2017.128","volume":"19","author":"I Micu","year":"2018","unstructured":"Micu, I., Plemel, J. R., Caprariello, A. V., Nave, K.-A., & Stys, P. K. (2018). Axo-myelinic neurotransmission: A novel mode of cell signalling in the central nervous system. Nature Reviews. Neuroscience, 19, 49\u201358.","journal-title":"Nature Reviews. Neuroscience"},{"key":"12_CR109","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s12035-013-8543-2","volume":"49","author":"E Mikaeili Agah","year":"2014","unstructured":"Mikaeili Agah, E., Parivar, K., & Joghataei, M. T. (2014). Therapeutic effect of transplanted human Wharton\u2019s jelly stem cell-derived oligodendrocyte progenitor cells (hWJ-MSC-derived OPCs) in an animal model of multiple sclerosis. Molecular Neurobiology, 49, 625\u2013632.","journal-title":"Molecular Neurobiology"},{"key":"12_CR110","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(11)70274-5","volume":"11","author":"DH Miller","year":"2012","unstructured":"Miller, D. H., Chard, D. T., & Ciccarelli, O. (2012). Clinically isolated syndromes. Lancet Neurology, 11, 157\u2013169.","journal-title":"Lancet Neurology"},{"key":"12_CR111","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1161\/STROKEAHA.113.002813","volume":"44","author":"N Miyamoto","year":"2013","unstructured":"Miyamoto, N., Maki, T., Pham, L.-D. D., Hayakawa, K., Seo, J. H., Mandeville, E. T., Mandeville, J. B., Kim, K.-W., Lo, E. H., & Arai, K. (2013). Oxidative stress interferes with white matter renewal after prolonged cerebral hypoperfusion in mice. Stroke\u2014A Journal of Cerebral Circulation, 44, 3516\u20133521.","journal-title":"Stroke\u2014A Journal of Cerebral Circulation"},{"key":"12_CR112","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/s42003-022-04248-1","volume":"5","author":"I Molina-Gonzalez","year":"2022","unstructured":"Molina-Gonzalez, I., Miron, V. E., & Antel, J. P. (2022). Chronic oligodendrocyte injury in central nervous system pathologies. Communications Biology, 5, 1274.","journal-title":"Communications Biology"},{"key":"12_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102129","volume":"43","author":"A Muehler","year":"2020","unstructured":"Muehler, A., Peelen, E., Kohlhof, H., Gr\u00f6ppel, M., & Vitt, D. (2020). Vidofludimus calcium, a next generation DHODH inhibitor for the treatment of relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders, 43, 102129.","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"12_CR114","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cmet.2020.05.019","volume":"32","author":"C Mukherjee","year":"2020","unstructured":"Mukherjee, C., Kling, T., Russo, B., Miebach, K., Kess, E., Schifferer, M., Pedro, L. D., Weikert, U., Fard, M. K., Kannaiyan, N., Rossner, M., Aicher, M.-L., Goebbels, S., Nave, K.-A., Kr\u00e4mer-Albers, E.-M., Schneider, A., & Simons, M. (2020). Oligodendrocytes provide antioxidant defense function for neurons by secreting ferritin heavy chain. Cell Metabolism, 32, 259\u2013272.e10.","journal-title":"Cell Metabolism"},{"key":"12_CR115","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12016-011-8287-6","volume":"42","author":"J Nakahara","year":"2012","unstructured":"Nakahara, J., Maeda, M., Aiso, S., & Suzuki, N. (2012). Current concepts in multiple sclerosis: Autoimmunity versus oligodendrogliopathy. Clinical Reviews in Allergy and Immunology, 42, 26\u201334.","journal-title":"Clinical Reviews in Allergy and Immunology"},{"key":"12_CR116","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrn2797","volume":"11","author":"K-A Nave","year":"2010","unstructured":"Nave, K.-A. (2010a). Myelination and the trophic support of long axons. Nature Reviews. Neuroscience, 11, 275\u2013283.","journal-title":"Nature Reviews. Neuroscience"},{"key":"12_CR117","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nature09614","volume":"468","author":"K-A Nave","year":"2010","unstructured":"Nave, K.-A. (2010b). Myelination and support of axonal integrity by glia. Nature, 468, 244\u2013252.","journal-title":"Nature"},{"key":"12_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2023.102782","volume":"83","author":"K-A Nave","year":"2023","unstructured":"Nave, K.-A., Asadollahi, E., & Sasmita, A. (2023). Expanding the function of oligodendrocytes to brain energy metabolism. Current Opinion in Neurobiology, 83, 102782.","journal-title":"Current Opinion in Neurobiology"},{"key":"12_CR119","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-cellbio-100913-013101","volume":"30","author":"K-A Nave","year":"2014","unstructured":"Nave, K.-A., & Werner, H. B. (2014). Myelination of the nervous system: Mechanisms and functions. Annual Review of Cell and Developmental Biology, 30, 503\u2013533.","journal-title":"Annual Review of Cell and Developmental Biology"},{"key":"12_CR120","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1001\/jamaneurol.2015.4807","volume":"73","author":"L Negrotto","year":"2016","unstructured":"Negrotto, L., Farez, M. F., & Correale, J. (2016). Immunologic effects of metformin and pioglitazone treatment on metabolic syndrome and multiple sclerosis. JAMA Neurology, 73, 520\u2013528.","journal-title":"JAMA Neurology"},{"key":"12_CR121","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nm.2324","volume":"17","author":"I Niki\u0107","year":"2011","unstructured":"Niki\u0107, I., Merkler, D., Sorbara, C., Brinkoetter, M., Kreutzfeldt, M., Bareyre, F. M., Br\u00fcck, W., Bishop, D., Misgeld, T., & Kerschensteiner, M. (2011). A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nature Medicine, 17, 495\u2013499.","journal-title":"Nature Medicine"},{"key":"12_CR122","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41593-019-0369-4","volume":"22","author":"J Niu","year":"2019","unstructured":"Niu, J., Tsai, H.-H., Hoi, K. K., Huang, N., Yu, G., Kim, K., Baranzini, S. E., Xiao, L., Chan, J. R., & Fancy, S. P. J. (2019). Aberrant oligodendroglial-vascular interactions disrupt the blood brain barrier triggering CNS inflammation. Nature Neuroscience, 22, 709\u2013718.","journal-title":"Nature Neuroscience"},{"key":"12_CR123","first-page":"596","volume":"25","author":"B Nourbakhsh","year":"2019","unstructured":"Nourbakhsh, B., & Mowry, E. M. (2019). Multiple sclerosis risk factors and pathogenesis. Continuum: Lifelong Learning in Neurology, 25, 596\u2013610.","journal-title":"Continuum: Lifelong Learning in Neurology"},{"key":"12_CR124","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/WCO.0000000000000622","volume":"31","author":"J Oh","year":"2018","unstructured":"Oh, J., Vidal-Jordana, A., & Montalban, X. (2018). Multiple sclerosis: Clinical aspects. Current Opinion in Neurology, 31, 752\u2013759.","journal-title":"Current Opinion in Neurology"},{"key":"12_CR125","doi-asserted-by":"publisher","first-page":"10647","DOI":"10.3390\/ijms130810647","volume":"13","author":"J Patel","year":"2012","unstructured":"Patel, J., & Balabanov, R. (2012). Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis. International Journal of Molecular Sciences, 13, 10647\u201310659.","journal-title":"International Journal of Molecular Sciences"},{"key":"12_CR126","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ana.1123","volume":"50","author":"JW Peterson","year":"2001","unstructured":"Peterson, J. W., B\u00f6, L., M\u00f6rk, S., Chang, A., & Trapp, B. D. (2001). Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Annals of Neurology, 50, 389\u2013400.","journal-title":"Annals of Neurology"},{"key":"12_CR127","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrneurol.2014.108","volume":"10","author":"A Petzold","year":"2014","unstructured":"Petzold, A., Wattjes, M. P., Costello, F., Flores-Rivera, J., Fraser, C. L., Fujihara, K., Leavitt, J., Marignier, R., Paul, F., Schippling, S., Sindic, C., Villoslada, P., Weinshenker, B., & Plant, G. T. (2014). The investigation of acute optic neuritis: A review and proposed protocol. Nature Reviews. Neurology, 10, 447\u2013458.","journal-title":"Nature Reviews. Neurology"},{"key":"12_CR128","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1172\/JCI90610","volume":"127","author":"T Philips","year":"2017","unstructured":"Philips, T., & Rothstein, J. D. (2017). Oligodendroglia: Metabolic supporters of neurons. The Journal of Clinical Investigation, 127, 3271\u20133280.","journal-title":"The Journal of Clinical Investigation"},{"key":"12_CR129","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1001\/archneurol.2010.99","volume":"67","author":"L Piccio","year":"2010","unstructured":"Piccio, L., Naismith, R. T., Trinkaus, K., Klein, R. S., Parks, B. J., Lyons, J. A., & Cross, A. H. (2010). Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. Archives of Neurology, 67, 707\u2013714.","journal-title":"Archives of Neurology"},{"key":"12_CR130","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/joim.13215","volume":"289","author":"F Piehl","year":"2021","unstructured":"Piehl, F. (2021). Current and emerging disease-modulatory therapies and treatment targets for multiple sclerosis. Journal of Internal Medicine, 289, 771\u2013791.","journal-title":"Journal of Internal Medicine"},{"key":"12_CR131","doi-asserted-by":"crossref","unstructured":"Pike, S. C., Welsh, N., Linzey, M., & Gilli, F. (2022). Theiler\u2019s virus-induced demyelinating disease as an infectious model of progressive multiple sclerosis. Frontiers in Molecular Neuroscience, 15, 1019799.","DOI":"10.3389\/fnmol.2022.1019799"},{"key":"12_CR132","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200025","volume":"9","author":"D Pitt","year":"2022","unstructured":"Pitt, D., Lo, C. H., Gauthier, S. A., Hickman, R. A., Longbrake, E., Airas, L. M., Mao-Draayer, Y., Riley, C., De Jager, P. L., Wesley, S., Boster, A., Topalli, I., Bagnato, F., Mansoor, M., Stuve, O., Kister, I., Pelletier, D., Stathopoulos, P., Dutta, R., & Lincoln, M. R. (2022). Toward precision phenotyping of multiple sclerosis. Neurology Neuroimmunology & Neuroinflammation, 9, e200025.","journal-title":"Neurology Neuroimmunology & Neuroinflammation"},{"key":"12_CR133","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/glia.23245","volume":"66","author":"JR Plemel","year":"2018","unstructured":"Plemel, J. R., Michaels, N. J., Weishaupt, N., Caprariello, A. V., Keough, M. B., Rogers, J. A., Yukseloglu, A., Lim, J., Patel, V. V., Rawji, K. S., Jensen, S. K., Teo, W., Heyne, B., Whitehead, S. N., Stys, P. K., & Yong, V. W. (2018). Mechanisms of lysophosphatidylcholine-induced demyelination: A primary lipid disrupting myelinopathy. Glia, 66, 327\u2013347.","journal-title":"Glia"},{"key":"12_CR134","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., Lublin, F. D., Montalban, X., O\u2019Connor, P., Sandberg-Wollheim, M., Thompson, A. J., Waubant, E., Weinshenker, B., & Wolinsky, J. S. (2011). Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of Neurology, 69, 292\u2013302.","journal-title":"Annals of Neurology"},{"key":"12_CR135","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H.-P., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O\u2019Connor, P. W., Sandberg-Wollheim, M., Thompson, A. J., Weinshenker, B. G., & Wolinsky, J. S. (2005). Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d. Annals of Neurology, 58, 840\u2013846.","journal-title":"Annals of Neurology"},{"key":"12_CR136","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3389\/fimmu.2018.00217","volume":"9","author":"G Ponath","year":"2018","unstructured":"Ponath, G., Park, C., & Pitt, D. (2018). The role of astrocytes in multiple sclerosis. Frontiers in Immunology, 9, 217.","journal-title":"Frontiers in Immunology"},{"key":"12_CR137","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12974-016-0522-x","volume":"13","author":"G Ponath","year":"2016","unstructured":"Ponath, G., Ramanan, S., Mubarak, M., Housley, W., Lee, S., Sahinkaya, F. R., Vortmeyer, A., Raine, C. S., & Pitt, D. (2016). A new perspective on the role of oligodendrocyte precursors in neuroinflammation. Journal of Neuroinflammation, 13, 56.","journal-title":"Journal of Neuroinflammation"},{"key":"12_CR138","first-page":"182","volume":"759","author":"C Procaccini","year":"2015","unstructured":"Procaccini, C., De Rosa, V., Pucino, V., Formisano, L., & Matarese, G. (2015). Animal models of multiple sclerosis. Eur. J. Pharmacol. Translational Value of Animal Models, 759, 182\u2013191.","journal-title":"Translational Value of Animal Models"},{"key":"12_CR139","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1272","volume":"9","author":"V Pytel","year":"2019","unstructured":"Pytel, V., Mat\u00edas-Guiu, J. A., Torre-Fuentes, L., Montero-Escribano, P., Maietta, P., Botet, J., \u00c1lvarez, S., G\u00f3mez-Pinedo, U., & Mat\u00edas-Guiu, J. (2019). Exonic variants of genes related to the vitamin D signaling pathway in the families of familial multiple sclerosis using whole-exome next generation sequencing. Brain and Behavior: A Cognitive Neuroscience Perspective, 9, e01272.","journal-title":"Brain and Behavior: A Cognitive Neuroscience Perspective"},{"key":"12_CR140","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/135245859900500307","volume":"5","author":"AD Rae-Grant","year":"1999","unstructured":"Rae-Grant, A. D., Eckert, N. J., Bartz, S., & Reed, J. F. (1999). Sensory symptoms of multiple sclerosis: A hidden reservoir of morbidity. Multiple Sclerosis (Houndmills, Basingstoke), 5, 179\u2013183.","journal-title":"Multiple Sclerosis (Houndmills, Basingstoke)"},{"key":"12_CR141","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/gm105","volume":"1","author":"SV Ramagopalan","year":"2009","unstructured":"Ramagopalan, S. V., & Ebers, G. C. (2009). Multiple sclerosis: Major histocompatibility complexity and antigen presentation. Genome Medicine, 1, 105.","journal-title":"Genome Medicine"},{"key":"12_CR142","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.it.2023.02.002","volume":"44","author":"RM Ransohoff","year":"2023","unstructured":"Ransohoff, R. M. (2023). Multiple sclerosis: Role of meningeal lymphoid aggregates in progression independent of relapse activity. Trends in Immunology, 44, 266\u2013275.","journal-title":"Trends in Immunology"},{"key":"12_CR143","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/nn.3168","volume":"15","author":"RM Ransohoff","year":"2012","unstructured":"Ransohoff, R. M. (2012). Animal models of multiple sclerosis: The good, the bad and the bottom line. Nature Neuroscience, 15, 1074\u20131077.","journal-title":"Nature Neuroscience"},{"key":"12_CR144","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nri1199","volume":"3","author":"DH Raulet","year":"2003","unstructured":"Raulet, D. H. (2003). Roles of the NKG2D immunoreceptor and its ligands. Nature Reviews. Immunology, 3, 781\u2013790.","journal-title":"Nature Reviews. Immunology"},{"key":"12_CR145","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1177\/0271678X16655551","volume":"36","author":"RG Rempe","year":"2016","unstructured":"Rempe, R. G., Hartz, A. M. S., & Bauer, B. (2016). Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers. Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 36, 1481\u20131507.","journal-title":"Official Journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"12_CR146","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S1474-4422(14)70250-9","volume":"14","author":"MA Rocca","year":"2015","unstructured":"Rocca, M. A., Amato, M. P., De Stefano, N., Enzinger, C., Geurts, J. J., Penner, I.-K., Rovira, A., Sumowski, J. F., Valsasina, P., Filippi, M., & MAGNIMS Study Group. (2015). Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurology, 14, 302\u2013317.","journal-title":"Lancet Neurology"},{"key":"12_CR147","doi-asserted-by":"publisher","first-page":"13275","DOI":"10.1038\/ncomms13275","volume":"7","author":"E Romanelli","year":"2016","unstructured":"Romanelli, E., Merkler, D., Mezydlo, A., Weil, M.-T., Weber, M. S., Niki\u0107, I., Potz, S., Meinl, E., Matznick, F. E. H., Kreutzfeldt, M., Ghanem, A., Conzelmann, K.-K., Metz, I., Br\u00fcck, W., Routh, M., Simons, M., Bishop, D., Misgeld, T., & Kerschensteiner, M. (2016). Myelinosome formation represents an early stage of oligodendrocyte damage in multiple sclerosis and its animal model. Nature Communications, 7, 13275.","journal-title":"Nature Communications"},{"key":"12_CR148","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.neuron.2016.05.016","volume":"91","author":"AS Saab","year":"2016","unstructured":"Saab, A. S., Tzvetavona, I. D., Trevisiol, A., Baltan, S., Dibaj, P., Kusch, K., M\u00f6bius, W., Goetze, B., Jahn, H. M., Huang, W., Steffens, H., Schomburg, E. D., P\u00e9rez-Samart\u00edn, A., P\u00e9rez-Cerd\u00e1, F., Bakhtiari, D., Matute, C., L\u00f6wel, S., Griesinger, C., Hirrlinger, J., Kirchhoff, F., & Nave, K.-A. (2016). Oligodendroglial NMDA receptors regulate glucose import and axonal energy metabolism. Neuron, 91, 119\u2013132.","journal-title":"Neuron"},{"key":"12_CR149","doi-asserted-by":"publisher","first-page":"8450","DOI":"10.12998\/wjcc.v10.i24.8450","volume":"10","author":"AA Safri","year":"2022","unstructured":"Safri, A. A., Nassir, C. M. N. C. M., Iman, I. N., Mohd Taib, N. H., Achuthan, A., & Mustapha, M. (2022). Diffusion tensor imaging pipeline measures of cerebral white matter integrity: An overview of recent advances and prospects. World Journal of Clinical Cases, 10, 8450\u20138462.","journal-title":"World Journal of Clinical Cases"},{"key":"12_CR150","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1523\/JNEUROSCI.4402-06.2007","volume":"27","author":"P Saikali","year":"2007","unstructured":"Saikali, P., Antel, J. P., Newcombe, J., Chen, Z., Freedman, M., Blain, M., Cayrol, R., Prat, A., Hall, J. A., & Arbour, N. (2007). NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 27, 1220\u20131228.","journal-title":"Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"key":"12_CR151","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nature14957","volume":"526","author":"J Samanta","year":"2015","unstructured":"Samanta, J., Grund, E. M., Silva, H. M., Lafaille, J. J., Fishell, G., & Salzer, J. L. (2015). Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination. Nature, 526, 448\u2013452.","journal-title":"Nature"},{"key":"12_CR152","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/jnr.24528","volume":"98","author":"A Sanabria-Castro","year":"2020","unstructured":"Sanabria-Castro, A., Flores-D\u00edaz, M., & Alape-Gir\u00f3n, A. (2020). Biological models in multiple sclerosis. Journal of Neuroscience Research, 98, 491\u2013508.","journal-title":"Journal of Neuroscience Research"},{"key":"12_CR153","unstructured":"Sanofi. (2022). A randomized, double-blind, placebo-controlled study of safety, tolerability, pharmacokinetics and pharmacodynamics of a single subcutaneous dose of GZ402668 in Men and Women With Progressive Multiple Sclerosis (Clinical trial registration No. NCT02977533). clinicaltrials.gov."},{"key":"12_CR154","first-page":"31","volume":"18","author":"F Sato","year":"2011","unstructured":"Sato, F., Tanaka, H., Hasanovic, F., & Tsunoda, I. (2011). Theiler\u2019s virus infection: Pathophysiology of demyelination and neurodegeneration. Pathophysiology, Pathophysiology of Demyelinating Disorders: Multiple Sclerosis Special Issue, 18, 31\u201341.","journal-title":"Pathophysiology, Pathophysiology of Demyelinating Disorders: Multiple Sclerosis Special Issue"},{"key":"12_CR155","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/s41593-023-01366-9","volume":"26","author":"E Sch\u00e4ffner","year":"2023","unstructured":"Sch\u00e4ffner, E., Bosch-Queralt, M., Edgar, J. M., Lehning, M., Strau\u00df, J., Fleischer, N., Kungl, T., Wieghofer, P., Berghoff, S. A., Reinert, T., Krueger, M., Morawski, M., M\u00f6bius, W., Barrantes-Freer, A., Stieler, J., Sun, T., Saher, G., Schwab, M. H., Wrede, C., Frosch, M., Prinz, M., Reich, D. S., Fl\u00fcgel, A., Stadelmann, C., Fledrich, R., Nave, K.-A., & Stassart, R. M. (2023). Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease. Nature Neuroscience, 26, 1218\u20131228.","journal-title":"Nature Neuroscience"},{"key":"12_CR156","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1084\/jem.20140540","volume":"211","author":"T Schneider-Hohendorf","year":"2014","unstructured":"Schneider-Hohendorf, T., Rossaint, J., Mohan, H., B\u00f6ning, D., Breuer, J., Kuhlmann, T., Gross, C. C., Flanagan, K., Sorokin, L., Vestweber, D., Zarbock, A., Schwab, N., & Wiendl, H. (2014). VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells. The Journal of Experimental Medicine, 211, 1833\u20131846.","journal-title":"The Journal of Experimental Medicine"},{"key":"12_CR157","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.572186","volume":"11","author":"MK Sen","year":"2020","unstructured":"Sen, M. K., Almuslehi, M. S. M., Shortland, P. J., Coorssen, J. R., & Mahns, D. A. (2020). Revisiting the pathoetiology of multiple sclerosis: Has the tail been wagging the mouse? Frontiers in Immunology, 11, 572186.","journal-title":"Frontiers in Immunology"},{"key":"12_CR158","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00210-021-02198-9","volume":"395","author":"S Singh","year":"2022","unstructured":"Singh, S., Sahu, K., Singh, C., & Singh, A. (2022). Lipopolysaccharide induced altered signaling pathways in various neurological disorders. Naunyn-Schmiedeberg's Archives of Pharmacology, 395, 285\u2013294.","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"12_CR159","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.3390\/molecules27175481","volume":"27","author":"A Skrzypczak-Wiercioch","year":"2022","unstructured":"Skrzypczak-Wiercioch, A., & Sa\u0142at, K. (2022). Lipopolysaccharide-induced model of neuroinflammation: Mechanisms of action, research application and future directions for its use. Molecules, 27, 5481.","journal-title":"Molecules"},{"key":"12_CR160","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.neuron.2014.11.006","volume":"84","author":"CD Sorbara","year":"2014","unstructured":"Sorbara, C. D., Wagner, N. E., Ladwig, A., Niki\u0107, I., Merkler, D., Kleele, T., Marinkovi\u0107, P., Naumann, R., Godinho, L., Bareyre, F. M., Bishop, D., Misgeld, T., & Kerschensteiner, M. (2014). Pervasive axonal transport deficits in multiple sclerosis models. Neuron, 84, 1183\u20131190.","journal-title":"Neuron"},{"key":"12_CR161","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1152\/physrev.00031.2018","volume":"99","author":"C Stadelmann","year":"2019","unstructured":"Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019). Myelin in the central nervous system: Structure, function, and pathology. Physiological Reviews, 99, 1381\u20131431.","journal-title":"Physiological Reviews"},{"key":"12_CR1610","doi-asserted-by":"crossref","unstructured":"Stangel, M., Kuhlmann, T., Matthews, P. M., Kilpatrick, T. J. (2017). Achievements and obstacles of remyelinating therapies in multiple sclerosis. Nature Reviews Neurology, 13, 742\u2013754.","DOI":"10.1038\/nrneurol.2017.139"},{"key":"12_CR162","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1056\/NEJMoa2201904","volume":"387","author":"L Steinman","year":"2022","unstructured":"Steinman, L., Fox, E., Hartung, H.-P., Alvarez, E., Qian, P., Wray, S., Robertson, D., Huang, D., Selmaj, K., Wynn, D., Cutter, G., Mok, K., Hsu, Y., Xu, Y., Weiss, M. S., Bosco, J. A., Power, S. A., Lee, L., Miskin, H. P., & Cree, B. A. C. (2022). Ublituximab versus teriflunomide in relapsing multiple sclerosis. The New England Journal of Medicine, 387, 704\u2013714.","journal-title":"The New England Journal of Medicine"},{"key":"12_CR163","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/jnen\/nlx023","volume":"76","author":"EMM Strijbis","year":"2017","unstructured":"Strijbis, E. M. M., Kooi, E.-J., van der Valk, P., & Geurts, J. J. G. (2017). Cortical remyelination is heterogeneous in multiple sclerosis. Journal of Neuropathology and Experimental Neurology, 76, 390\u2013401.","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"12_CR164","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/nprot.2006.285","volume":"1","author":"IM Stromnes","year":"2006","unstructured":"Stromnes, I. M., & Goverman, J. M. (2006). Active induction of experimental allergic encephalomyelitis. Nature Protocols, 1, 1810\u20131819.","journal-title":"Nature Protocols"},{"key":"12_CR165","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.12688\/f1000research.20906.1","volume":"8","author":"PK Stys","year":"2019","unstructured":"Stys, P. K., & Tsutsui, S. (2019). Recent advances in understanding multiple sclerosis. F1000Research, 8, 2100.","journal-title":"F1000Research"},{"key":"12_CR166","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrn3275","volume":"13","author":"PK Stys","year":"2012","unstructured":"Stys, P. K., Zamponi, G. W., Van Minnen, J., & Geurts, J. J. G. (2012). Will the real multiple sclerosis please stand up? Nature Reviews. Neuroscience, 13, 507\u2013514.","journal-title":"Nature Reviews. Neuroscience"},{"key":"12_CR167","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3988\/jcn.2018.14.2.129","volume":"14","author":"WS Tae","year":"2018","unstructured":"Tae, W. S., Ham, B. J., Pyun, S. B., Kang, S. H., & Kim, B. J. (2018). Current clinical applications of diffusion-tensor imaging in neurological disorders. Journal of Clinical Neurology (Korea), 14, 129\u2013140.","journal-title":"Journal of Clinical Neurology (Korea)"},{"key":"12_CR168","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/jnr.20573","volume":"81","author":"SB Tekk\u00f6k","year":"2005","unstructured":"Tekk\u00f6k, S. B., Brown, A. M., Westenbroek, R., Pellerin, L., & Ransom, B. R. (2005). Transfer of glycogen-derived lactate from astrocytes to axons via specific monocarboxylate transporters supports mouse optic nerve activity. Journal of Neuroscience Research, 81, 644\u2013652.","journal-title":"Journal of Neuroscience Research"},{"key":"12_CR169","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/B978-008045046-9.01760-5","volume-title":"Encyclopedia of neuroscience","author":"V Tepav\u010devi\u0107","year":"2009","unstructured":"Tepav\u010devi\u0107, V., & Baron-Van Evercoeren, A. (2009). Transplantation of myelin forming cells. In L. R. Squire (Ed.), Encyclopedia of neuroscience (pp. 1141\u20131152). Academic Press."},{"key":"12_CR170","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., Correale, J., Fazekas, F., Filippi, M., Freedman, M. S., Fujihara, K., Galetta, S. L., Hartung, H. P., Kappos, L., Lublin, F. D., Marrie, R. A., Miller, A. E., Miller, D. H., Montalban, X., Mowry, E. M., Sorensen, P. S., Tintor\u00e9, M., Traboulsee, A. L., Trojano, M., Uitdehaag, B. M. J., Vukusic, S., Waubant, E., Weinshenker, B. G., Reingold, S. C., & Cohen, J. A. (2018). Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurology, 17, 162\u2013173.","journal-title":"Lancet Neurology"},{"key":"12_CR171","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","volume":"13","author":"AT Toosy","year":"2014","unstructured":"Toosy, A. T., Mason, D. F., & Miller, D. H. (2014). Optic neuritis. Lancet Neurology, 13, 83\u201399.","journal-title":"Lancet Neurology"},{"key":"12_CR172","first-page":"32","volume":"35","author":"L Torre-Fuentes","year":"2020","unstructured":"Torre-Fuentes, L., Moreno-Jim\u00e9nez, L., Pytel, V., Mat\u00edas-Guiu, J. A., G\u00f3mez-Pinedo, U., & Mat\u00edas-Guiu, J. (2020). Experimental models of demyelination and remyelination. Neurological England. Ed., 35, 32\u201339.","journal-title":"Neurological England. Ed."},{"key":"12_CR173","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","volume":"31","author":"BD Trapp","year":"2008","unstructured":"Trapp, B. D., & Nave, K.-A. (2008). Multiple sclerosis: An immune or neurodegenerative disorder? Annual Review of Neuroscience, 31, 247\u2013269.","journal-title":"Annual Review of Neuroscience"},{"key":"12_CR174","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2217\/17460794.3.6.579","volume":"3","author":"I Tsunoda","year":"2008","unstructured":"Tsunoda, I. (2008). Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection. Future Virology, 3, 579\u2013593.","journal-title":"Future Virology"},{"key":"12_CR175","first-page":"84","volume":"759","author":"TF Vandamme","year":"2015","unstructured":"Vandamme, T. F. (2015). Rodent models for human diseases. European Journal of Pharmacology Translational Value of Animal Models, 759, 84\u201389.","journal-title":"European Journal of Pharmacology Translational Value of Animal Models"},{"key":"12_CR176","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.nic.2016.12.001","volume":"27","author":"A Vidal-Jordana","year":"2017","unstructured":"Vidal-Jordana, A., & Montalban, X. (2017). Multiple Sclerosis. Neuroimaging Clinics of North America, 27, 195\u2013204.","journal-title":"Neuroimaging Clinics of North America"},{"key":"12_CR177","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.neuron.2018.12.023","volume":"101","author":"ME Witte","year":"2019","unstructured":"Witte, M. E., Schumacher, A.-M., Mahler, C. F., Bewersdorf, J. P., Lehmitz, J., Scheiter, A., S\u00e1nchez, P., Williams, P. R., Griesbeck, O., Naumann, R., Misgeld, T., & Kerschensteiner, M. (2019). Calcium influx through plasma-membrane nanoruptures drives axon degeneration in a model of multiple sclerosis. Neuron, 101, 615\u2013624.e5.","journal-title":"Neuron"},{"key":"12_CR178","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11940-019-0574-1","volume":"21","author":"L Wooliscroft","year":"2019","unstructured":"Wooliscroft, L., Silbermann, E., Cameron, M., & Bourdette, D. (2019). Approaches to remyelination therapies in multiple sclerosis. Current Treatment Options in Neurology, 21, 34.","journal-title":"Current Treatment Options in Neurology"},{"key":"12_CR179","unstructured":"WP1303_APITOPE PROGRAMS_PIPELINE_Worg Pharmaceuticals (Zhejiang) Co., Ltd. [WWW Document], n.d.. https:\/\/www.worgpharma.com\/index.php?c=category&id=85. Accessed 18 Jan 2024"},{"key":"12_CR180","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/brain\/awh007","volume":"127","author":"J Wuerfel","year":"2004","unstructured":"Wuerfel, J., Bellmann-Strobl, J., Brunecker, P., Aktas, O., McFarland, H., Villringer, A., & Zipp, F. (2004). Changes in cerebral perfusion precede plaque formation in multiple sclerosis: A longitudinal perfusion MRI study. Brain: A Journal of Neurology, 127, 111\u2013119.","journal-title":"Brain: A Journal of Neurology"},{"key":"12_CR181","doi-asserted-by":"publisher","first-page":"14128","DOI":"10.1523\/JNEUROSCI.3491-13.2014","volume":"34","author":"YL Xing","year":"2014","unstructured":"Xing, Y. L., R\u00f6th, P. T., Stratton, J. A. S., Chuang, B. H. A., Danne, J., Ellis, S. L., Ng, S. W., Kilpatrick, T. J., & Merson, T. D. (2014). Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination. The Journal of Neuroscience, 34, 14128\u201314146.","journal-title":"The Journal of Neuroscience"},{"key":"12_CR182","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1084\/jem.20132477","volume":"211","author":"R Yamasaki","year":"2014","unstructured":"Yamasaki, R., Lu, H., Butovsky, O., Ohno, N., Rietsch, A. M., Cialic, R., Wu, P. M., Doykan, C. E., Lin, J., Cotleur, A. C., Kidd, G., Zorlu, M. M., Sun, N., Hu, W., Liu, L., Lee, J.-C., Taylor, S. E., Uehlein, L., Dixon, D., Gu, J., Floruta, C. M., Zhu, M., Charo, I. F., Weiner, H. L., & Ransohoff, R. M. (2014). Differential roles of microglia and monocytes in the inflamed central nervous system. The Journal of Experimental Medicine, 211, 1533\u20131549.","journal-title":"The Journal of Experimental Medicine"},{"key":"12_CR183","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.cell.2014.10.011","volume":"159","author":"MSY Yeung","year":"2014","unstructured":"Yeung, M. S. Y., Zdunek, S., Bergmann, O., Bernard, S., Salehpour, M., Alkass, K., Perl, S., Tisdale, J., Possnert, G., Brundin, L., Druid, H., & Fris\u00e9n, J. (2014). Dynamics of oligodendrocyte generation and myelination in the human brain. Cell, 159, 766\u2013774.","journal-title":"Cell"},{"issue":"190","key":"12_CR184","first-page":"2510","volume":"1950","author":"F Zaguia","year":"2013","unstructured":"Zaguia, F., Saikali, P., Ludwin, S., Newcombe, J., Beauseigle, D., McCrea, E., Duquette, P., Prat, A., Antel, J. P., & Arbour, N. (2013). Cytotoxic NKG2C+ CD4 T cells target oligodendrocytes in multiple sclerosis. Journal of Immunology Baltimore, Md, 1950(190), 2510\u20132518.","journal-title":"Journal of Immunology Baltimore, Md"},{"key":"12_CR185","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0165-5728(98)00047-2","volume":"87","author":"R Zeine","year":"1998","unstructured":"Zeine, R., Pon, R., Ladiwala, U., Antel, J. P., Filion, L. G., & Freedman, M. S. (1998). Mechanism of gammadelta T cell-induced human oligodendrocyte cytotoxicity: Relevance to multiple sclerosis. Journal of Neuroimmunology, 87, 49\u201361.","journal-title":"Journal of Neuroimmunology"},{"key":"12_CR186","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.neurol.2018.03.006","volume":"174","author":"H Z\u00e9phir","year":"2018","unstructured":"Z\u00e9phir, H. (2018). Progress in understanding the pathophysiology of multiple sclerosis. Revue Neurologique (Paris), 174, 358\u2013363.","journal-title":"Revue Neurologique (Paris)"},{"key":"12_CR187","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3390\/cells9040843","volume":"9","author":"J Zhan","year":"2020","unstructured":"Zhan, J., Mann, T., Joost, S., Behrangi, N., Frank, M., & Kipp, M. (2020). The Cuprizone model: Dos and do nots. Cells, 9, 843.","journal-title":"Cells"},{"key":"12_CR188","doi-asserted-by":"publisher","DOI":"10.1101\/2023.12.18.572120","volume-title":"Distinct transcriptomic and epigenomic responses of mature oligodendrocytes during disease progression in a mouse model of multiple sclerosis","author":"C Zheng","year":"2023","unstructured":"Zheng, C., Herv\u00e9, B., Meijer, M., Rodr\u00edguez-Kirby, L.A.R., Cacais, A.O.G., Kukanja, P., Kabbe, M., Olsson, T., Agirre, E., Castelo-Branco, G., (2023). Distinct transcriptomic and epigenomic responses of mature oligodendrocytes during disease progression in a mouse model of multiple sclerosis."},{"key":"12_CR189","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1474-4422(23)00377-0","volume":"23","author":"B Zierfuss","year":"2024","unstructured":"Zierfuss, B., Larochelle, C., & Prat, A. (2024). Blood-brain barrier dysfunction in multiple sclerosis: Causes, consequences, and potential effects of therapies. Lancet Neurology, 23, 95\u2013109.","journal-title":"Lancet Neurology"},{"key":"12_CR190","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/1352458509350311","volume":"16","author":"V Zipoli","year":"2010","unstructured":"Zipoli, V., Goretti, B., Hakiki, B., Siracusa, G., Sorbi, S., Portaccio, E., & Amato, M. P. (2010). Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. Multiple Sclerosis (Houndmills, Basingstoke), 16, 62\u201367.","journal-title":"Multiple Sclerosis (Houndmills, Basingstoke)"},{"key":"12_CR191","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13024-022-00538-8","volume":"17","author":"M Zirngibl","year":"2022","unstructured":"Zirngibl, M., Assinck, P., Sizov, A., Caprariello, A. V., & Plemel, J. R. (2022). Oligodendrocyte death and myelin loss in the cuprizone model: An updated overview of the intrinsic and extrinsic causes of cuprizone demyelination. Molecular Neurodegeneration, 17, 34.","journal-title":"Molecular Neurodegeneration"}],"container-title":["Advances in Neurobiology","Physiology and Pathophysiology of Oligodendroglia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-87919-7_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T19:06:50Z","timestamp":1749668810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-87919-7_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783031879180","9783031879197"],"references-count":192,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-87919-7_12","relation":{},"ISSN":["2190-5215","2190-5223"],"issn-type":[{"value":"2190-5215","type":"print"},{"value":"2190-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"12 June 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}